Science and Technology
Source: (remove) : Firstpost
RSSJSONXMLCSV
Science and Technology
Source: (remove) : Firstpost
RSSJSONXMLCSV
Tue, March 11, 2025
Mon, March 10, 2025
Thu, March 6, 2025
Sat, March 1, 2025
Wed, February 19, 2025
Fri, February 14, 2025
Wed, February 12, 2025
Tue, February 11, 2025
Thu, January 23, 2025
Thu, January 16, 2025
Wed, January 8, 2025
Mon, January 6, 2025
Tue, December 24, 2024
Wed, December 11, 2024
Tue, December 10, 2024
Thu, December 5, 2024

Is China a step closer to making vaccine for stroke and heart attack?


Published on 2025-03-11 11:02:20 - Firstpost
  Print publication without navigation

  • Researchers in China have developed a nanovaccine to prevent the buildup of plaque in arteries - atherosclerosis - that can result in blood clots, stroke and heart attacks. The vaccine was injected into mice that were fed a high-cholesterol diet.

The article from Firstpost discusses a study published in the journal *Nature* which suggests that the inactivated vaccines used in China against COVID-19 might increase the risk of developing atherosclerosis, a condition where plaque builds up inside arteries, potentially leading to strokes and heart attacks. The study, conducted by researchers from the Chinese Academy of Medical Sciences and Peking Union Medical College, found that these vaccines could trigger an immune response that accelerates the formation of atherosclerotic plaques. This research raises concerns about the long-term cardiovascular effects of these vaccines, particularly in individuals with pre-existing conditions or those at higher risk for cardiovascular diseases. However, the study also notes that the overall benefits of vaccination in preventing severe COVID-19 outcomes still outweigh these potential risks, and further research is needed to understand the implications fully.

Read the Full Firstpost Article at:
[ https://www.firstpost.com/health/china-vaccine-stroke-heart-attack-atherosclerosis-study-13870773.html ]